NK012
NK012
NK012 (pronunciation: en-kay-zero-one-two) is a nanoparticle drug delivery system that is designed to enhance the effectiveness of chemotherapy drugs. It is a type of nanomedicine that is used in the treatment of various types of cancer.
Etymology
The term "NK012" is derived from the initials of the Nanocarrier Co., Ltd., the Japanese company that developed the drug, and the number 012, which was assigned to it during the development process.
Function
NK012 is a polymer-based nanoparticle that is designed to deliver a high concentration of the chemotherapy drug SN-38 directly to cancer cells. The nanoparticle is coated with a layer of polyethylene glycol (PEG), which helps to protect the drug from being broken down by the body's immune system. This allows the drug to circulate in the bloodstream for a longer period of time, increasing its chances of reaching the cancer cells.
Related Terms
External links
- Medical encyclopedia article on NK012
- Wikipedia's article - NK012
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski